Literature DB >> 30627973

Phytomedicines in the Treatment of Migraine.

Thilinie Rajapakse1,2, William Jeptha Davenport3,4,5.   

Abstract

Migraine is a disabling neurovascular disorder with few targeted, tolerable and effective treatments. Phytomedicines, or plant-based medicinal formulations, hold great promise in the identification of novel therapeutic targets in migraine. Many patients also turn toward herbal and plant-based therapies for the treatment of their migraines as clinical and preclinical evidence of efficacy increases. Patients seek effective and tolerable treatments instead of or in addition to current conventional pharmacologic therapies. We review some phytomedicines potentially useful for migraine treatment-feverfew (Tanacetum parthenium), butterbur (Petasites hybridus), marijuana (Cannabis spp.), Saint John's Wort (Hypericum perforatum) and the Damask rose (Rosa × damascena)-with respect to their mechanisms of action and evidence for treatment of migraine. The evidence for feverfew is mixed; butterbur is effective with potential risks of hepatotoxicity related to preparation; marijuana has not been shown to be effective in migraine treatment, and data are scant; Saint John's Wort shows relevant physiological activity but is a hepatic enzyme inducer and lacks clinical studies for this purpose; the Damask rose when used in topical preparations did not show efficacy in one clinical trial. Other plant preparations have been considered for migraine treatment but most without blinded randomized, placebo-controlled trial evidence.

Entities:  

Year:  2019        PMID: 30627973     DOI: 10.1007/s40263-018-0597-2

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  111 in total

1.  Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura.

Authors:  Dan Levy; Andrew M Strassman
Journal:  J Neurophysiol       Date:  2002-12       Impact factor: 2.714

Review 2.  Cannabinoids in clinical practice.

Authors:  E M Williamson; F J Evans
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 3.  Pharmacology and effects of cannabis: a brief review.

Authors:  C H Ashton
Journal:  Br J Psychiatry       Date:  2001-02       Impact factor: 9.319

4.  Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.

Authors:  C W Vaughan; M Connor; E E Bagley; M J Christie
Journal:  Mol Pharmacol       Date:  2000-02       Impact factor: 4.436

5.  Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation.

Authors:  M Tognetto; S Amadesi; S Harrison; C Creminon; M Trevisani; M Carreras; M Matera; P Geppetti; A Bianchi
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

6.  Calcium channel blockade in vascular smooth muscle cells: major hypotensive mechanism of S-petasin, a hypotensive sesquiterpene from Petasites formosanus.

Authors:  G J Wang; A Y Shum; Y L Lin; J F Liao; X C Wu; J Ren; C F Chen
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

7.  Marijuana-produced changes in pain tolerance. Experienced and non-experienced subjects.

Authors:  S L Milstein; K MacCannell; G Karr; S Clark
Journal:  Int Pharmacopsychiatry       Date:  1975

Review 8.  Neuroprotective antioxidants from marijuana.

Authors:  A J Hampson; M Grimaldi; M Lolic; D Wink; R Rosenthal; J Axelrod
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

9.  Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus.

Authors:  O A Thomet; U N Wiesmann; A Schapowal; C Bizer; H U Simon
Journal:  Biochem Pharmacol       Date:  2001-04-15       Impact factor: 5.858

10.  The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.

Authors:  V Pfaffenrath; H C Diener; M Fischer; M Friede; H H Henneicke-von Zepelin
Journal:  Cephalalgia       Date:  2002-09       Impact factor: 6.292

View more
  5 in total

1.  Authors' Reply to Diener: "Phytomedicines in the Treatment of Migraine".

Authors:  Thilinie Rajapakse; William Jeptha Davenport
Journal:  CNS Drugs       Date:  2019-06       Impact factor: 5.749

2.  Comment on: "Phytomedicines in the Treatment of Migraine".

Authors:  Hans-Christoph Diener
Journal:  CNS Drugs       Date:  2019-06       Impact factor: 5.749

Review 3.  Petasites for Migraine Prevention: New Data on Mode of Action, Pharmacology and Safety. A Narrative Review.

Authors:  Jürgen Borlak; Hans-Christoph Diener; Johanna Kleeberg-Hartmann; Karl Messlinger; Stephen Silberstein
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.086

Review 4.  The Use of Antioxidants in the Treatment of Migraine.

Authors:  Marta Goschorska; Izabela Gutowska; Irena Baranowska-Bosiacka; Katarzyna Barczak; Dariusz Chlubek
Journal:  Antioxidants (Basel)       Date:  2020-01-28

5.  Anti-Inflammatory and Neuromodulatory Effects Induced by Tanacetum parthenium Water Extract: Results from In Silico, In Vitro and Ex Vivo Studies.

Authors:  Lucia Recinella; Annalisa Chiavaroli; Viviana di Giacomo; Marco Daniel Antolini; Alessandra Acquaviva; Sheila Leone; Luigi Brunetti; Luigi Menghini; Gunes Ak; Gokhan Zengin; Simonetta Cristina Di Simone; Claudio Ferrante; Giustino Orlando
Journal:  Molecules       Date:  2020-12-23       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.